![Kabeer Aziz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kabeer Aziz
Directeur/Membre du Conseil chez
AN2 THERAPEUTICS, INC.
Fortune : 243 580 $ au 31/05/2026
Profil
Kabeer Aziz is the founder of Adjuvant Capital LP, founded in 2018, holding the title of Partner.
Current jobs include Director at MinervaX ApS, Pulmocide Ltd., Univercells SA, Frontier Nutrition, Inc., and LimmaTech Biologics AG (since 2023), as well as Independent Director at AN2 Therapeutics, Inc. (since 2019).
Former jobs include Director at Quantoom Biosciences SA (2022–2023), Associate at Metalmark Capital LLC (2013–2015), Analyst at Greenhill & Co., Inc. (2011–2013), and Senior Associate at Global Health Investment Fund (2015–2018).
Education includes an undergraduate degree from The Leonard N Stern School of Business, conferred in 2011.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 10/04/2026 | 56 254 ( 0,16% ) | 243 580 $ | 31/05/2026 |
Postes actifs de Kabeer Aziz
| Sociétés | Poste | Début |
|---|---|---|
| AN2 THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/11/2019 |
Adjuvant Capital LP
 Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital invests in companies located in the United States. The firm targets companies operating in the fields of life sciences. It provides equity, mezzanine and debt financing for later stage capital requirements with an investment size of USD 10 to 25 million. | Fondateur | 10/01/2018 |
Minervax ApS
 Minervax ApS Pharmaceuticals: MajorHealth Technology Develops prophylactic vaccines for pregnant women and older adults | Directeur/Membre du Conseil | - |
Pulmocide Ltd.
 Pulmocide Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops inhaled medicines for viral and fungal infections of the respiratory diseases | Directeur/Membre du Conseil | - |
Frontier Nutrition, Inc.
 Frontier Nutrition, Inc. Food: Specialty/CandyConsumer Non-Durables Develops, manufactures and markets snacks | Directeur/Membre du Conseil | - |
Univercells SA
 Univercells SA Miscellaneous Commercial ServicesCommercial Services Operates as a life sciences company which develops biologics | Directeur/Membre du Conseil | - |
LimmaTech Biologics AG
 LimmaTech Biologics AG BiotechnologyHealth Technology Operates as a clinical-stage biotech company that develops vaccines for prevention of life-threatening diseases | Directeur/Membre du Conseil | 09/10/2023 |
Anciens postes connus de Kabeer Aziz
| Sociétés | Poste | Fin |
|---|---|---|
Quantoom Biosciences SA
 Quantoom Biosciences SA Pharmaceuticals: OtherHealth Technology Operates as a therapeutic development and bio manufacturing company | Directeur/Membre du Conseil | 01/12/2023 |
Global Health Investment Fund
 Global Health Investment Fund Investment ManagersFinance Acts as Family of Funds | Analyste en capital-investissement | 31/12/2018 |
| ░░░░░░░░░ ░░░░░░░ ░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Kabeer Aziz
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
85
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Metalmark Capital LLC
 Metalmark Capital LLC Investment ManagersFinance Metalmark Capital invests in middle market companies located in the United States primarily in North America. The firm focuses on healthcare, business & commercials, food & agribusiness, industrials & infrastructure and real assets. It provides financing for buyout and growth transactions. | Finance |
Greenhill & Co., Inc.
 Greenhill & Co., Inc. Investment Banks/BrokersFinance Operates as an investment bank that provides financial advisory services | Finance |
Minervax ApS
Minervax ApS Pharmaceuticals: MajorHealth Technology Develops prophylactic vaccines for pregnant women and older adults | Health Technology |
Pulmocide Ltd.
Pulmocide Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops inhaled medicines for viral and fungal infections of the respiratory diseases | Health Technology |
The Leonard N Stern School of Business
 The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Global Health Investment Fund
Global Health Investment Fund Investment ManagersFinance Acts as Family of Funds | Finance |
Univercells SA
Univercells SA Miscellaneous Commercial ServicesCommercial Services Operates as a life sciences company which develops biologics | Commercial Services |
Frontier Nutrition, Inc.
Frontier Nutrition, Inc. Food: Specialty/CandyConsumer Non-Durables Develops, manufactures and markets snacks | Consumer Non-Durables |
Adjuvant Capital LP
Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital invests in companies located in the United States. The firm targets companies operating in the fields of life sciences. It provides equity, mezzanine and debt financing for later stage capital requirements with an investment size of USD 10 to 25 million. | Finance |
LimmaTech Biologics AG
LimmaTech Biologics AG BiotechnologyHealth Technology Operates as a clinical-stage biotech company that develops vaccines for prevention of life-threatening diseases | Health Technology |
AN2 Therapeutics, Inc.
 AN2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics | Health Technology |
Quantoom Biosciences SA
Quantoom Biosciences SA Pharmaceuticals: OtherHealth Technology Operates as a therapeutic development and bio manufacturing company | Health Technology |
